Details for Patent: 8,506,929
✉ Email this page to a colleague
Which drugs does patent 8,506,929 protect, and when does it expire?
Patent 8,506,929 protects AMYVID and is included in one NDA.
This patent has fifty-one patent family members in thirty-three countries.
Summary for Patent: 8,506,929
| Title: | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
| Abstract: | This invention relates to a method of imaging amyloid deposits and to styrylpyridine compounds, and methods of making radiolabeled styrylpyridine compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits. |
| Inventor(s): | Kung; Hank F. (Wynnewood, PA), Kung; Mei-Ping (Wynnewood, PA) |
| Assignee: | The Trustees of the University of Pennsylvania (Philadelphia, PA) |
| Application Number: | 12/186,072 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; Use; |
Drugs Protected by US Patent 8,506,929
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-001 | Apr 6, 2012 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | AMYVID IS A RADIOACTIVE DIAGNOSTIC AGENT FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING OF THE BRAIN TO ESTIMATE BETA-AMYLOID NEURITIC PLAQUE DENSITY IN ADULT PATIENTS WITH COGNITIVE IMPAIRMENT | ⤷ Sign Up | ||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-002 | Apr 6, 2012 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | AMYVID IS A RADIOACTIVE DIAGNOSTIC AGENT FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING OF THE BRAIN TO ESTIMATE BETA-AMYLOID NEURITIC PLAQUE DENSITY IN ADULT PATIENTS WITH COGNITIVE IMPAIRMENT | ⤷ Sign Up | ||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-003 | Apr 6, 2012 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | AMYVID IS A RADIOACTIVE DIAGNOSTIC AGENT FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING OF THE BRAIN TO ESTIMATE BETA-AMYLOID NEURITIC PLAQUE DENSITY IN ADULT PATIENTS WITH COGNITIVE IMPAIRMENT | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,506,929
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1999109 | ⤷ Sign Up | C300600 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1999109 | ⤷ Sign Up | CA 2013 00035 | Denmark | ⤷ Sign Up |
| European Patent Office | 1999109 | ⤷ Sign Up | PA2013016 | Lithuania | ⤷ Sign Up |
| European Patent Office | 1999109 | ⤷ Sign Up | 92232 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 1999109 | ⤷ Sign Up | C20130016 00076 | Estonia | ⤷ Sign Up |
| European Patent Office | 1999109 | ⤷ Sign Up | 13C0034 | France | ⤷ Sign Up |
| European Patent Office | 1999109 | ⤷ Sign Up | 139 5017-2013 | Slovakia | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
